India to France: Rivaroxaban Export Trade Route
India has recorded 49 verified shipments of Rivaroxaban exported to France, representing a combined trade value of $1.3M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $26.0K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 64% of total export value with 16 shipments worth $811.4K USD. On the buying side, CSP is the largest importer in France with $576.3K USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, MICRO LABS LIMITED, AJANTA PHARMA LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to France Rivaroxaban corridor is one of India's established pharmaceutical export routes, with 49 shipments documented worth a combined $1.3M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's rivaroxaban manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $26.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 31.0%, placing it at rank #16 among India's top rivaroxaban export destinations globally.
On the import side, key buyers of Indian rivaroxaban in France include CSP, E.P.DIS, CSP VIATRIS SANTE AT CSP- LABO, and 5 others. CSP is the single largest importer with 5 shipments valued at $576.3K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portBombay Air Cargo
Market Position
- Global rank#16
- Annual growth+31.0%
- Demand growth+27.7%
- Regulatory ease68/100
Top 10 Indian Rivaroxaban Exporters to France
Showing top 10 of 5 Indian suppliers exporting Rivaroxaban to France, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $50.7K per shipment | 16 | $811.4K | 63.7% |
| 2 | MICRO LABS LIMITED Avg $21.1K per shipment | 18 | $380.5K | 29.9% |
| 3 | AJANTA PHARMA LIMITED Avg $6.3K per shipment | 10 | $63.2K | 5.0% |
| 4 | MICRO LABS LIMITED Avg $3.2K per shipment | 4 | $12.7K | 1.0% |
| 5 | PINNACLE LIFE SCIENCE PRIVATE LIMITED Avg $6.3K per shipment | 1 | $6.3K | 0.5% |
This table shows the top 10 of 5 Indian companies exporting rivaroxaban to France, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, MICRO LABS LIMITED, AJANTA PHARMA LIMITED, MICRO LABS LIMITED , PINNACLE LIFE SCIENCE PRIVATE LIMITED. MYLAN LABORATORIES LIMITED is the dominant supplier with 16 shipments worth $811.4K USD, giving it a 64% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Rivaroxaban Importers in France
Showing top 10 of 8 known buyers in France receiving Rivaroxaban shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rivaroxaban in France include CSP, E.P.DIS, CSP VIATRIS SANTE AT CSP- LABO,, E P DIS, PLANET PHARMA SA, among 8 total buyers. The largest importer is CSP, accounting for $576.3K USD across 5 shipments — representing 45% of all rivaroxaban imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CSP | 5 | $576.3K | 45.2% |
| 2 | E.P.DIS | 12 | $235.6K | 18.5% |
| 3 | CSP VIATRIS SANTE AT CSP- LABO, | 11 | $235.1K | 18.4% |
| 4 | E P DIS | 5 | $128.0K | 10.0% |
| 5 | PLANET PHARMA SA | 10 | $63.2K | 5.0% |
| 6 | E.P.DIS.,., | 1 | $16.9K | 1.3% |
| 7 | E.P.DIS | 4 | $12.7K | 1.0% |
| 8 | TEDIS SA | 1 | $6.3K | 0.5% |
Top 10 Rivaroxaban Formulations Imported by France
Showing top 10 of 47 product formulations shipped on the India to France Rivaroxaban route, ranked by trade value
France imports a wide range of rivaroxaban formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — RIVAROXABAN VIATRIS 20 MG 28BL PACKS 2X14 S BLISTER 274358 PACKS X 2X14 S 7682024 NOS — accounts for $374.0K USD across 2 shipments. There are 47 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RIVAROXABAN VIATRIS 20 MG 28BL PACKS 2X14 S BLISTER 274358 PACKS X 2X14 S 7682024 NOS | 2 | $374.0K | 29.4% |
| 2 | HARMLESS MEDICINES RIVAROXABAN TAB 20MG28BL FR VIA Rivaroxaban Tablets 204741 PACKS | 1 | $141.0K | 11.1% |
| 3 | VAROXA 20 RIVAROXABAN TABLETS 20MG3x10`S QTY-8155TAX DOCUMENT NO:712202658/30.09.2023 | 1 | $62.8K | 4.9% |
| 4 | HARMLESS MEDICINES RIVAROXABAN TAB 15MG28BL FR VIA 103004 PACKS | 1 | $56.7K | 4.5% |
| 5 | VAROXA 20 (RIVAROXABAN TABLETS 20MG)( 3X10`S ) ( QTY- 8085.000 )TAX INV NO: 701209992/25.03.2025 | 1 | $56.6K | 4.4% |
| 6 | RIVAROXABAN TAB 10MG 30BL FR VIA (PACKS:3 X 10S BLISTER) (93979 PACKS X 3X10'S=2819370 NOS) | 1 | $54.5K | 4.3% |
| 7 | VAROXA 20 (RIVAROXABAN 20MG TABLETS) (3X10'S) (QTY- 5929.000) TAX INV NO: 712203095/25.07.2024 | 1 | $44.2K | 3.5% |
| 8 | VAROXA 10 RIVAROXABAN 10MG TABLETS3x10`S QTY-6120TAX DOCUMENT NO:701207896/30.09.2023 | 1 | $42.4K | 3.3% |
| 9 | RIVAROXABAN TAB 15MG 28BL FR VIA (Packs: 2 X 14?S BLISTER) (68924.000X PACKS 2X14'S BLISTER=1929872 ) | 1 | $38.5K | 3.0% |
| 10 | RIVAROXABAN TAB 15MG 28BL FR VIA (Packs: 2 X 14?S BLISTER) (67964.000X 2 X 14'SBLISTER=1902992 NOS) | 1 | $38.0K | 3.0% |
Showing top 10 of 47 Rivaroxaban formulations imported by France on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
Bombay Air Cargo handles the highest volume with 9 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's rivaroxaban exports to France are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 16 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, MICRO LABS LIMITED, AJANTA PHARMA LIMITED — together account for 99% of total trade value on this route. The average shipment value of $26.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines rivaroxaban tab 20mg28bl fr via rivaroxaban tablets 204741 packs and varoxa 20 rivaroxaban tablets 20mg3x10`s qty-8155tax document no:712202658/30.09.2023, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CSP is the largest importer with 5 shipments worth $576.3K USD — representing 45% of all rivaroxaban imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.3M
- Avg. Shipment
- $26.0K
- Suppliers
- 5
- Buyers
- 8
- Transit (Sea)
- ~27 days
- Annual Growth
- +31.0%
Related Analysis
Reverse Direction
France → India — Rivaroxaban (Import)Other Rivaroxaban Routes
Unlock the Full India to France Rivaroxaban Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 49 shipments on this route.
Frequently Asked Questions — India to France Rivaroxaban Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rivaroxaban to France?
The leading Indian exporters of Rivaroxaban to France are MYLAN LABORATORIES LIMITED, MICRO LABS LIMITED, AJANTA PHARMA LIMITED. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 64% of total trade value on this route.
Q What is the total value of Rivaroxaban exports from India to France?
India exports Rivaroxaban to France worth approximately $1.3M USD across 49 recorded shipments. The average value per shipment is $26.0K USD.
Q Which ports does India use to ship Rivaroxaban to France?
The most active port of origin is Bombay Air Cargo with 9 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to France for Rivaroxaban?
The average transit time for Rivaroxaban shipments from India to France is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to France Rivaroxaban trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.0% with demand growth tracking at 27.7%. The route is ranked #16 among India's top Rivaroxaban export destinations globally.
Q How many suppliers are active on the India to France Rivaroxaban route?
There are currently 5 active Indian suppliers exporting Rivaroxaban to France. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 64% of total shipment value.
Q Who are the main importers of Rivaroxaban from India in France?
The leading importers of Indian Rivaroxaban in France include CSP, E.P.DIS, CSP VIATRIS SANTE AT CSP- LABO,, E P DIS, PLANET PHARMA SA. CSP is the largest buyer with 5 shipments worth $576.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to France export trade corridor identified from Indian Customs (DGFT) records for Rivaroxaban.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 8 importers in France matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 49 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
49 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists